We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

AGILENT

Agilent provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling... read more Featured Products: More products

Download Mobile App




Simple New Method Identifies Food Allergies

By LabMedica International staff writers
Posted on 14 Jul 2014
Print article
Image: The 7100 Capillary Electrophoresis system (Photo courtesy of Agilent).
Image: The 7100 Capillary Electrophoresis system (Photo courtesy of Agilent).
A highly-sensitive method has been developed that can quickly and accurately identify proteins that cause allergic reactions even at very low concentrations.

Food allergies occur when the body's immune system mistakes a harmless food protein for a threat and attacks it as it would normally do with a bacterium or a virus and this causes symptoms like swelling, rashes, pain, and even life-threatening anaphylactic shocks.

Scientists at the Ecole Polytechnique Fédérale de Lausanne (Switzerland) developed a highly-sensitive method that uses a patient's immunoglobulin E (IgE) to determine specifically which protein induces allergic responses in them. The method uses a well-established technique called immunoaffinity capillary electrophoresis (IACE). First, IgE antibodies from the patient's blood are isolated by interaction with magnetic beads that are coated with a different type of antibody.

Blood serum of a patient allergic to the cow’s milk and control serum from a blood donor who had no allergies was tested. First, IgE antibodies from the patient's blood are isolated by interaction with magnetic beads that are coated with a different type of antibody. The antibody coated bead recognizes and binds to the patient's IgE antibodies. This takes place inside a long and narrow glass tube called a capillary. The bound antibodies are then flushed out of the capillary which are powerfully attached to the magnetic beads through a process called crosslinking, and this keeps them from detaching. The beads with the patient's IgE are then placed again inside the capillary.

The IACE-UV investigations for total IgE analysis was carried out with a 7100A Capillary Electrophoresis (CE) apparatus (Agilent; Waldbronn, Germany). Component-resolved diagnostics (CRD) were performed using the IACE with Matrix Assisted Laser Desorption/Ionization Mass Spectrometry (MALDI-TOF-MS, Microflex instrument (Bruker Daltonics; Bremen, Germany). The method offers a personalized way to identify the exact proteins that can cause food allergies to a patient, which can help develop an effective treatment.

The authors concluded that their method was quicker that the laborious and resource-intensive diagnostic methods used currently as it does not require the detection and quantification of a patient's specific IgE antibodies. The methodology provides higher accuracy than conventional allergy-testing methods, as it can detect tiny amounts of allergic proteins, even if they are unexpected and rare. This also means that the method can be extended beyond milk to other foods like nuts and wheat products. The study was published on June 10, 2014, in the journal Analytical Chemistry.

Related Links:

Ecole Polytechnique Fédérale de Lausanne
Agilent 
Bruker Daltonics 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.